<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">26782080</PMID>
      <DateCompleted>
        <Year>2016</Year>
        <Month>11</Month>
        <Day>14</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2016</Year>
        <Month>12</Month>
        <Day>30</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1745-2422</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>13</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2016</Year>
            </PubDate>
          </JournalIssue>
          <Title>Expert review of medical devices</Title>
          <ISOAbbreviation>Expert Rev Med Devices</ISOAbbreviation>
        </Journal>
        <ArticleTitle>From drug eluting stents to bioresorbable scaffolds; to new horizons in PCI.</ArticleTitle>
        <Pagination>
          <StartPage>271</StartPage>
          <EndPage>286</EndPage>
          <MedlinePgn>271-86</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1586/17434440.2016.1143356</ELocationID>
        <Abstract>
          <AbstractText>Drug eluting stents and particularly the fully bioresorbable drug-eluting scaffolds herald a new era in percutaneous treatment of coronary artery disease. There has been tremendous progress in drug eluting stents with fully biodegradable coating polymers and polymer-free devices with reservoir technology planting the anti-proliferative drug. Despite significant decreases in in-stent restenosis rates with drug eluting stents, limitations still remain before we are able to develop fully bioresorbable scaffolds. Enhanced mechanical flexibility that provides superior conformability to the vessel wall, resumption of the vasoreactivity in the follow-up period and improving visualization on non-invasive imaging modalities are some of the supremacies of the fully bioresorbable scaffolds. In this review, we aim to give a general view on the latest developments in metallic drug eluting stents and fully bioresorbable scaffolds.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Tenekecioglu</LastName>
            <ForeName>Erhan</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Cardiology , ThoraxCentre, Erasmus Medical Center , Rotterdam , The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bourantas</LastName>
            <ForeName>Christos</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>b Institute of Cardiovascular Sciences , University College of London , London , UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>c Department of Cardiology , Barts Health NHS Trust , London , UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Abdelghani</LastName>
            <ForeName>Mohammad</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>d Academic Medical Center , University of Amsterdam , Amsterdam , The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zeng</LastName>
            <ForeName>Yaping</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Cardiology , ThoraxCentre, Erasmus Medical Center , Rotterdam , The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Silva</LastName>
            <ForeName>Rafael Cavalcante</ForeName>
            <Initials>RC</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Cardiology , ThoraxCentre, Erasmus Medical Center , Rotterdam , The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tateishi</LastName>
            <ForeName>Hiroki</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Cardiology , ThoraxCentre, Erasmus Medical Center , Rotterdam , The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sotomi</LastName>
            <ForeName>Yohei</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>d Academic Medical Center , University of Amsterdam , Amsterdam , The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Onuma</LastName>
            <ForeName>Yoshinobu</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Cardiology , ThoraxCentre, Erasmus Medical Center , Rotterdam , The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>YÄ±lmaz</LastName>
            <ForeName>Mustafa</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>e Department of Cardiology , Bursa Postgraduate Research and Education Hospital , Bursa , Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Serruys</LastName>
            <ForeName>Patrick W</ForeName>
            <Initials>PW</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Cardiology , ThoraxCentre, Erasmus Medical Center , Rotterdam , The Netherlands.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>f International Centre for Circulatory Health , Imperial College , London , UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2016</Year>
          <Month>02</Month>
          <Day>12</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Expert Rev Med Devices</MedlineTA>
        <NlmUniqueID>101230445</NlmUniqueID>
        <ISSNLinking>1743-4440</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D011108">Polymers</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D020341" MajorTopicYN="Y">Absorbable Implants</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054855" MajorTopicYN="Y">Drug-Eluting Stents</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018579" MajorTopicYN="N">Patient Selection</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062645" MajorTopicYN="N">Percutaneous Coronary Intervention</DescriptorName>
          <QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011108" MajorTopicYN="N">Polymers</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054457" MajorTopicYN="N">Tissue Scaffolds</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Drug eluting stents</Keyword>
        <Keyword MajorTopicYN="N">anti-proliferative drug</Keyword>
        <Keyword MajorTopicYN="N">biodegradable polymer</Keyword>
        <Keyword MajorTopicYN="N">durable polymer</Keyword>
        <Keyword MajorTopicYN="N">fully bioresorbable scaffold</Keyword>
        <Keyword MajorTopicYN="N">polymer-free drug eluting stent</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2016</Year>
          <Month>1</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2016</Year>
          <Month>1</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2016</Year>
          <Month>11</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">26782080</ArticleId>
        <ArticleId IdType="doi">10.1586/17434440.2016.1143356</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
